Back to Screener

Financial Services

Hercules Capital, Inc.(HCXY)

Live Price

Offline

$24.97

+0.56% today

1Y Change

+0.52%

Window

Jun 25, 2025 โ†’ Jun 23, 2026

Market Cap
$3.50B
Revenue Growth
+18.3%
EPS Growth
+18.0%
Dividend Yield
6.3%

Coverage: 249 bars ยท Jun 25, 2025 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Hercules Capital, Inc. (HCXY) is a Financial Services stock with a market cap of $3.50B and listed on NYSE. The stock last traded around $24.97 and up 0.5% across the available one-year price window (Jun 25, 2025 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of +18.3%, EPS growth of +18.0%, a dividend yield of 6.3%. What stands out right now is revenue +18.3%, EPS +18.0%, free cash flow -258.4% with operating margin 87.8% and ROIC 83.1%. The dividend matters to the case here, with a current yield around 6.3%. Valuation is more restrained than many high-expectation growth names at P/E 13.0 and price/sales 7.1. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines HCXY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Above sector median

+18.3% vs +3.4% peer median

Operating Margin

Above sector median

+87.8% vs +4.7% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on Apr 30, 2026, but the surprise data is still limited.

The operating story is still moving forward

Revenue is running at +18.3% and EPS at +18.0%, with operating margin around 87.8%.

Shareholder return is still part of the story

The stock is still offering a dividend yield around 6.3%, which matters if the thesis depends on income as much as growth.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged +0.1% over the next 5 trading days and finished higher after 3 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
Apr 30, 2026
โ€”+0.0%+0.0%+0.9%
2026
Feb 12, 2026
-2.5%-0.1%+0.0%+0.2%
2025
Oct 30, 2025
+27.3%+0.4%+0.1%+0.2%

Benchmark Edge

HCXY vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

HCXY

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

HCXY Max Drawdown

-3.81%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for HCXY and SPY.

Calendar-year return history is still loading or unavailable.
Hercules Capital, Inc. logo

Company Overview

Hercules Capital, Inc.

New York Stock Exchange

Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million and $250 million in equity per transactions. It invests generally between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in North America and Europe.

Leadership
None
IPO Date
Sep 27, 2018
Employees
100
Street Address
400 Hamilton Avenue Suite 310Palo Alto, 94301United States
Mailing
San Mateo, MD
Region
San Mateo, MD, US
Reporting Currency
USD
Investor Line
650 289 3060
Last Updated
Apr 29, 2026
CIK: 0001280784ISIN: US4270968476CUSIP: 427096847
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
13.0
EV/EBITDA
13.3
Price/Sales
7.1
Price/Book
2.0

Growth

Revenue
+18.3%
EPS
+18.0%
Free Cash Flow
-258.4%

Profitability

Gross Margin
110.8%
Operating Margin
87.8%
Net Margin
68.9%
ROE
15.8%
ROIC
83.1%

Balance Sheet

Debt/Equity
1.04
Current Ratio
5.79

Earnings Reports

๐Ÿ“… Last reportedApr 30, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
Apr 30, 26
โ€”
Est 0.48
โ€”
โ€”
Est 141204.0B
โ€”
โ€”
Feb 12, 26
โœ—
0.48
Est 0.49
-2.5%
137400.0B
Est 141519.4B
-2.9%
โ€”
Oct 30, 25
โœ“
0.61
Est 0.48
+27.3%
116682.0B
Est 136954.1B
-14.8%
โ€”
Jul 31, 25
โœ—
0.41
Est 0.47
-12.9%
79843.0B
Est 128890.8B
-38.0%
โ€”
May 1, 25
โœ—
0.45
Est 0.46
-3.1%
102099.0B
Est 125433.0B
-18.6%
โ€”
Dec 31, 23
0.76
Est โ€”
โ€”
125450.0B
Est โ€”
โ€”
โ€”
Dec 31, 22
773.22
Est โ€”
โ€”
157119.0B
Est โ€”
โ€”
โ€”
Sep 30, 22
386.61
Est โ€”
โ€”
81408.0B
Est โ€”
โ€”
โ€”
Jun 30, 22
322.97
Est โ€”
โ€”
68731.0B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.